Loading...

206 posters, 13 topics, 5 sessions, 713 authors, 293 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

AAPS 104th Annual Meeting

May 2-5, 2026 | Lihue, HI

AAPS 104th Annual Meeting banner

D104

Outcomes Of Omental Fat-augmented Free Flap Breast Reconstruction Across Bmi Categories

Part of Topic

Breast Reconstruction

Objective: 

    • BMI is a key determinant in autologous breast reconstruction.
    • Low BMI: limited donor tissue, yet higher satisfaction with autologous vs. implant-based reconstruction.
    • High BMI: adequate tissue but increased donor-site morbidity and wound complications.
    • The omental fat-augmented free flap (O-FAFF) utilizes laparoscopic harvest and may broaden autologous reconstruction options across BMI groups.
    • Objective: Compare outcomes across low (<18.5), normal (18.5–24.9), and high (≥25) BMI patients.

Methods: 

    • Design: Retrospective review of consecutive O-FAFF breast reconstructions by a single surgeon.
    • Outcomes: Major and minor complications, abdominal donor-site morbidity, and revision procedures.
    • Analysis: Fisher’s exact test for unadjusted comparisons.
    • Adjusted analysis: Logistic regression controlling for preoperative radiotherapy.

Results/Conclusion: 

    • O-FAFF demonstrates comparable safety across BMI groups, with no significant differences in overall or major complication rates.
    • Major complications were rare, and delayed wound healing in low BMI patients did not remain significant after adjustment for radiation.
    • No abdominal donor-site complications were observed in high BMI patients, supporting the benefit of laparoscopic harvest with minimal incision burden.
    • Revision procedures were common across all cohorts as part of staged reconstruction, with no significant differences in overall revision patterns.
    • Reconstructive volume was reliably achieved, with combined omentum and fat grafting approximating mastectomy specimen weight across BMI categories.
    • Clinical implications:
    • Expands autologous options for low BMI patients beyond implants
    • May reduce donor-site morbidity in high BMI patients at increased risk for wound complications

 

aaps2026 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.